Tech Company Financing Transactions
Kiyatec Funding Round
Kiyatec secured a Series A funding round on 5/24/2012. Backers included Nexus Medical Partners, Technology Capital and Upstate Carolina Angel Network.
Transaction Overview
Company Name
Announced On
5/24/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Nexus Medical Partners (Lead Investor) (Gregory Zaic)
Proceeds Purpose
Proceeds from the initial financing will be used to advance two 3D cell-based assays for more predictive evaluation of cancer efficacy and certain kinds of liver toxicity for drug and biologic candidates.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
900-B West Faris Rd.
Greenville, SC 29605
USA
Greenville, SC 29605
USA
Phone
Website
Email Address
Overview
Guided by the company's underlying principle of renewing life through advanced technology, KIYATEC personnel work to deliver enabling 3D cell culture tools for the pharmaceutical, biomedical and life science industries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Gevaert
Chief Operating Officer
Lillia Holmes
Chief Scientific Officer
Tessa DesRochers
VP - Operations
Timothy Decker
VP - Regulatory Affairs
Cecile Vibat
Browse more venture capital transactions:
Prev: 5/24/2012: Quick Technologies venture capital transaction
Next: 5/24/2012: InstaMed venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs